Company registration number 13776714 (England and Wales)
MEDICO LEGAL UK CHAMBERS (HOLDINGS) LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
MEDICO LEGAL UK CHAMBERS (HOLDINGS) LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
MEDICO LEGAL UK CHAMBERS (HOLDINGS) LTD
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
3
100
100
Current assets
Debtors
5
-
0
336,347
Creditors: amounts falling due within one year
6
-
0
(136,347)
Net current assets
-
0
200,000
Net assets
100
200,100
Capital and reserves
Called up share capital
7
100
100
Profit and loss reserves
-
0
200,000
Total equity
100
200,100

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 20 November 2025 and are signed on its behalf by:
Dr M D Appleyard
Director
Company registration number 13776714 (England and Wales)
MEDICO LEGAL UK CHAMBERS (HOLDINGS) LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Medico Legal UK Chambers (Holdings) Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Mentor House, Ainsworth Street, Blackburn, Lancashire, BB1 6AY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

MEDICO LEGAL UK CHAMBERS (HOLDINGS) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
100
100
4
Subsidiaries

Details of the company's subsidiaries at 31 March 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Medico Legal UK Chambers Limited
Mentor House, Ainsworth Street, Blackburn, Lancashire, United Kingdom, BB1 6AY
Ordinary shares
100.00
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
-
0
336,347
6
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
-
0
136,347
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary 1 shares of £1 each
24
24
24
24
Ordinary 2 shares of £1 each
24
24
24
24
Ordinary 3 shares of £1 each
26
26
26
26
Ordinary 4 shares of £1 each
26
26
26
26
100
100
100
100
2025-03-31 2024-04-01 false false false 21 November 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr M D Appleyard Dr L F Bacon 13776714 2024-04-01 2025-03-31 13776714 2025-03-31 13776714 2024-03-31 13776714 core:WithinOneYear 2025-03-31 13776714 core:WithinOneYear 2024-03-31 13776714 core:ShareCapital 2025-03-31 13776714 core:ShareCapital 2024-03-31 13776714 core:RetainedEarningsAccumulatedLosses 2025-03-31 13776714 core:RetainedEarningsAccumulatedLosses 2024-03-31 13776714 core:ShareCapitalOrdinaryShareClass1 2025-03-31 13776714 core:ShareCapitalOrdinaryShareClass1 2024-03-31 13776714 core:ShareCapitalOrdinaryShareClass2 2025-03-31 13776714 core:ShareCapitalOrdinaryShareClass2 2024-03-31 13776714 core:ShareCapitalOrdinaryShareClass3 2025-03-31 13776714 core:ShareCapitalOrdinaryShareClass3 2024-03-31 13776714 core:ShareCapitalOrdinaryShareClass4 2025-03-31 13776714 core:ShareCapitalOrdinaryShareClass4 2024-03-31 13776714 core:ShareCapitalOrdinaryShares 2025-03-31 13776714 core:ShareCapitalOrdinaryShares 2024-03-31 13776714 bus:Director1 2024-04-01 2025-03-31 13776714 2023-04-01 2024-03-31 13776714 core:Subsidiary1 2024-04-01 2025-03-31 13776714 core:Subsidiary1 1 2024-04-01 2025-03-31 13776714 core:CurrentFinancialInstruments 2024-03-31 13776714 core:CurrentFinancialInstruments 2025-03-31 13776714 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 13776714 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 13776714 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 13776714 bus:OrdinaryShareClass4 2024-04-01 2025-03-31 13776714 bus:OrdinaryShareClass1 2025-03-31 13776714 bus:OrdinaryShareClass1 2024-03-31 13776714 bus:OrdinaryShareClass2 2025-03-31 13776714 bus:OrdinaryShareClass2 2024-03-31 13776714 bus:OrdinaryShareClass3 2025-03-31 13776714 bus:OrdinaryShareClass3 2024-03-31 13776714 bus:OrdinaryShareClass4 2025-03-31 13776714 bus:OrdinaryShareClass4 2024-03-31 13776714 bus:AllOrdinaryShares 2025-03-31 13776714 bus:AllOrdinaryShares 2024-03-31 13776714 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13776714 bus:FRS102 2024-04-01 2025-03-31 13776714 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13776714 bus:Director2 2024-04-01 2025-03-31 13776714 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13776714 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP